326 related articles for article (PubMed ID: 1686120)
1. Enhancement of athletic performance with drugs. An overview.
Wagner JC
Sports Med; 1991 Oct; 12(4):250-65. PubMed ID: 1686120
[TBL] [Abstract][Full Text] [Related]
2. Abuse of drugs used to enhance athletic performance.
Wagner JC
Am J Hosp Pharm; 1989 Oct; 46(10):2059-67. PubMed ID: 2683762
[TBL] [Abstract][Full Text] [Related]
3. Ergogenic drugs in sports.
Knopp WD; Wang TW; Bach BR
Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
[TBL] [Abstract][Full Text] [Related]
4. Drugs and sport. Research findings and limitations.
Clarkson PM; Thompson HS
Sports Med; 1997 Dec; 24(6):366-84. PubMed ID: 9421862
[TBL] [Abstract][Full Text] [Related]
5. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
6. Nutritional supplements and ergogenic AIDS.
Liddle DG; Connor DJ
Prim Care; 2013 Jun; 40(2):487-505. PubMed ID: 23668655
[TBL] [Abstract][Full Text] [Related]
7. [The use of drugs to improve athletic performance].
Kuipers H; Hartgens F
Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
[TBL] [Abstract][Full Text] [Related]
8. Position stand on androgen and human growth hormone use.
Hoffman JR; Kraemer WJ; Bhasin S; Storer T; Ratamess NA; Haff GG; Willoughby DS; Rogol AD
J Strength Cond Res; 2009 Aug; 23(5 Suppl):S1-S59. PubMed ID: 19620932
[TBL] [Abstract][Full Text] [Related]
9. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
[TBL] [Abstract][Full Text] [Related]
10. Ergogenic Aids and Testing in Pediatric Athletes.
Ergun-Longmire B; Greydanus DE; Patel DR
Pediatr Ann; 2023 Jun; 52(6):e207-e212. PubMed ID: 37280002
[TBL] [Abstract][Full Text] [Related]
11. Analytical strategy for detecting doping agents in hair.
Thieme D; Grosse J; Sachs H; Mueller RK
Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
[TBL] [Abstract][Full Text] [Related]
12. Popular ergogenic drugs and supplements in young athletes.
Calfee R; Fadale P
Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
[TBL] [Abstract][Full Text] [Related]
13. Ergogenic aids: a review of basic science, performance, side effects, and status in sports.
Tokish JM; Kocher MS; Hawkins RJ
Am J Sports Med; 2004 Sep; 32(6):1543-53. PubMed ID: 15310585
[TBL] [Abstract][Full Text] [Related]
14. Doping in sport: effects, harm and misconceptions.
Birzniece V
Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
[TBL] [Abstract][Full Text] [Related]
15. Chemical warfare: drugs in sports.
Percy EC
West J Med; 1980 Dec; 133(6):478-84. PubMed ID: 6110283
[TBL] [Abstract][Full Text] [Related]
16. Performance-enhancing drugs, fair competition, and Olympic sport.
Catlin DH; Murray TH
JAMA; 1996 Jul; 276(3):231-7. PubMed ID: 8667569
[TBL] [Abstract][Full Text] [Related]
17. Popular sports supplements and ergogenic aids.
Juhn M
Sports Med; 2003; 33(12):921-39. PubMed ID: 12974658
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents.
Smith DA; Perry PJ
Ann Pharmacother; 1992 May; 26(5):653-9. PubMed ID: 1591427
[TBL] [Abstract][Full Text] [Related]
19. Ergogenic risks elevate health risks in young athletes.
Giesemer BA
Pediatr Ann; 2003 Nov; 32(11):733-7. PubMed ID: 22111154
[TBL] [Abstract][Full Text] [Related]
20. Risk profile of male college athletes who use performance-enhancing substances.
Buckman JF; Yusko DA; White HR; Pandina RJ
J Stud Alcohol Drugs; 2009 Nov; 70(6):919-23. PubMed ID: 19895768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
